Rachel Eclov Email & Phone Number
Vice President, Corporate Strategy and Scientific Affairs @ Kriya Therapeutics, Inc.
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Rachel Eclov Location
- Saint Paul, MN, US
Rachel Eclov Work
- Vice President, Corporate Strategy and Scientific Affairs @ (October 2025 - Present)
- Vice President Research and Early Development @ (April 2025 - October 2025)
- Sr. Director, Ophthalmology Development Lead @ (March 2023 - April 2025)
- Director, Development Project Leader @ (February 2022 - March 2023)
- Associate Director, Preclinical Gene Therapy @ (January 2021 - February 2022)
- Senior Preclinical Scientist of Gene Therapy @ (June 2018 - January 2021)
- Resident Head @ (August 2015 - June 2018)
- Postdoctoral Scholar @ (July 2013 - June 2018)
- Graduate Student @ (September 2007 - March 2013)
- Research Assistant @ (June 2007 - August 2007)
- Research Assistant @ (September 2006 - April 2007)
- Stanford Summer Research Program Fellow @ (June 2006 - August 2006)
- Research Assistant @ (January 2006 - June 2006)
Rachel Eclov Education
- University of California, San Francisco
Doctor of Philosophy (Ph.D.) (Pharmaceutical Sciences and Pharmacogenomics)
2007-2013 - University of Minnesota
Bachelor of Arts (Chemistry)
2005-2007 - Bemidji State University
Chemistry
2005-2005 - Lancaster University
Chemistry
2004-2004 - University of Minnesota Crookston
Chemistry
2003-2004
Rachel Eclov Skills
- AAV
- Assay Development
- Biochemistry
- Budget Management
- Cancer Immunotherapy
- Cell Biology
- Cell Culture
- Chemistry
- Communication
- Cross-functional Team Leadership
- Development Programs
- Development Strategy
- Drug Development
- Early Development
- Flow Cytometry
- Gene Expression
- Gene Therapy
- Genetics
- HPLC
- IND
- Immunology
- In Vitro
- Intellectual Property
- Mass Spectrometry
- Microscopy
- Molecular Biology
- Non-clinical
- Ophthalmology
- PCR
- Pharmacogenomics
- Pharmacology
- Phase I
- Polymerase Chain Reaction (PCR)
- Pre-clinical Studies
- Presentations
- Program Leadership
- Project Leadership
- Project Teams
- Protein Chemistry
- Protein Expression
- Protein Purification
- Rare Diseases
- Regulatory Interactions
- Regulatory Submissions
- Research
- Research and Development (R&D)
- Strategic Thinking
- Subject Matter Experts
- Team Leadership
- Transduction
- Transfection
- Translational Science
- Western Blotting
Rachel Eclov Summary
- Rachel Eclov, based in Saint Paul, MN, US, is currently a Vice President, Corporate Strategy and Scientific Affairs at Kriya Therapeutics, Inc.. Rachel Eclov brings experience from previous roles at Kriya Therapeutics, Inc. and BridgeBio. Rachel Eclov holds a 2007 - 2013 Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences and Pharmacogenomics @ University of California, San Francisco. With a robust skill set that includes AAV, Assay Development, Biochemistry, Budget Management, Cancer Immunotherapy and more. Rachel Eclov has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Rachel Eclov?
Find contact details for 700 million professionals.
Others Named Rachel Eclov
Top Kriya Therapeutics, Inc. Employees
Dan Manning
Senior Vice President External Engagement
Denver, CO, US
Shankar Ramaswamy
Co-Founder and Chief Executive Officer
United States
Britt Petty
President Manufacturing and Technical Operations
Durham, NC, US
Gregory di Russo
Chief Medical Officer
West Windsor Township, NJ, US
Katherine Eade
Chief Legal Officer
United States
Rich Guerra
VP Manufacturing | Plant Manager
Chapel Hill, NC, US
Mari Tandy
SVP, QA
Raleigh, NC, US
Erik Hughes
SVP, Technical Development
Raleigh, NC, US
Wayne Yount
Senior Vice President, Analytical and Formulation Sciences
Chapel Hill, NC, US
Sherry Clough
Vice President Supply Chain
Chapel Hill, NC, US
Mark Chen
Chief Operating Officer
United States
Amy Harman
SVP, Clinical Sciences
Nazareth, PA, US
Brandon Burch
Vice President, Regulatory Affairs
Chapel Hill, NC, US
Y. Chen
Senior Vice President, Head of Finance
Los Altos, CA, US
Brian Furmanski
Chief Regulatory Officer at Kriya Therapeutics
Chapel Hill, NC, US
Zhu Pirot
Vice President, Gene Therapy Translational and Analytical Sciences
California, United States
Leslie Dirisio
SVP, Head of Clinical Business Operations
New York, NY, US
Claire Pasquinelli
VP, CMC Program Management
Raleigh, NC, US
Rachel Eclov
Vice President, Corporate Strategy and Scientific Affairs
Saint Paul, MN, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co